| Ytd | 23.14% | |
| 1y | 70.72% |
| Open | 57.18 | Prev Close | 57.08 | Low | 56.03 | High | 58.36 | Mkt Cap | 8.84B |
| Vol | 1.86M | Avg Vol | 2.34M | EPS | -0.70 | P/E | N/A | Forward P/E | 24.11 |
| Beta | 1.27 | Short Ratio | 4.99 | Inst. Own | 96.00% | Dividend | 0.20 | Div Yield | 0.35 |
| Ex Div Date | 09-21 | Earning | 11-03 | 50-d Avg | 58.70 | 200-d Avg | 47.70 | 1yr Est | 58.75 |
10x Genomics won a $4.8 million patent infringement lawsuit against Qiagen subsidiary Parse Bioscien
Deutsche Bank AG acquired a new stake in Bruker Corporation (NASDAQ: BRKR) in the second quarter, ac
Bank of New York Mellon Corp acquired a new stake in Bruker Corporation (NASDAQ: BRKR) during the un
Citigroup analyst Brendan Digan maintains Bruker (NASDAQ:BRKR) with a Neutral and lowers the pric
The S&P 500 and Dow set records as Palantir and Caterpillar earnings powered chips higher, while
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular se
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'
Bruker (NASDAQ:BRKR) affirms FY2026 Adj EPS guidance from $2.10-$2.15 to $2.10-$2.15 vs $2.12 analys
Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.49 per share which beat the analyst consensus